The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Selective Killing of Vaccinia Virus by LL-37: Implications for Eczema Vaccinatum
Abstract
Possible bioterrorism with smallpox has led to the resumption of smallpox (vaccinia virus) immunization. One complication, eczema vaccinatum, occurs primarily in patients with atopic dermatitis (AD). Skin lesions of patients with AD, but not psoriasis, is deficient in the cathelicidin antimicrobial peptide (LL-37) and human β-defensin-2 (HBD-2). We hypothesized that this defect may explain the susceptibility of patients with AD to eczema vaccinatum. The Wyeth vaccine strain of vaccinia virus was incubated with varying concentrations of human (LL-37) and murine (CRAMP) cathelicidins, human α-defensin (HBD-1, HBD-2), and a control peptide. Outcomes included quantification of viral PFU, vaccinia viral gene expression by quantitative real-time RT-PCR, and changes in virion structure by transmission electron microscopy. CRAMP knockout mice and control animals were inoculated by skin pricks with 2 × 105 PFU of vaccinia and examined daily for pox development. Physiologic amounts of human and murine cathelicidins (10–50 μM), but not human defensins, which had antibacterial activity, resulted in the in vitro reduction of vaccinia viral plaque formation (p < 0.0001), vaccinia mRNA expression (p < 0.001), and alteration of vaccinia virion structure. In vivo vaccinia pox formation occurred in four of six CRAMP knockout animals and in only one of 15 control mice (p < 0.01). These data support a role for cathelicidins in the inhibition of orthopox virus (vaccinia) replication both in vitro and in vivo. Susceptibility of patients with AD to eczema vaccinatum may be due to a deficiency of cathelicidin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Self-citation(1988) · World Health Organization eBooks · Cited by 1,574
A peptide antibiotic from human skin
Harder, J., Bartels, J., Christophers, E., & Schröder, J.-M. (1997) · Nature · doi:10.1038/43088 · Cited by 1,363
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Self-citationFrohm, M., Agerberth, B., Ahangari, G., Ståhle-Bäckdahl, M., Lidén, S., Wigzell, H., & Gudmundsson, G. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15258 · Cited by 803
Dorschner, R. A., Pestonjamasp, V. K., Tamakuwala, S., Ohtake, T., Rudisill, J., Nizet, V., Agerberth, B., Gudmundsson, G. H., & Gallo, R. L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01340.x · Cited by 567
Self-citationDirect inactivation of viruses by human granulocyte defensins
Daher, K. A., Selsted, M. E., & Lehrer, R. I. (1986) · Journal of Virology · doi:10.1128/jvi.60.3.1068-1074.1986 · Cited by 533
Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network
Schmelz, M., Sodeik, B., Ericsson, M., Wolffe, E. J., Shida, H., Hiller, G., & Griffiths, G. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.130-147.1994 · Cited by 385
Biology and clinical relevance of naturally occurring antimicrobial peptides
Gallo, R. L., Murakami, M., Ohtake, T., & Zaiou, M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.129801 · Cited by 291
Self-citationEvaluation of the Inactivation of Infectious Herpes Simplex Virus by Host-Defense Peptides
Yasin, B., Pang, M., Turner, J. S., Cho, Y., Dinh, N.-N., Waring, A. J., Lehrer, R. I., & Wagar, E. A. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050457 · Cited by 210
Intracellular and extracellular vaccinia virions enter cells by different mechanisms.
Vanderplasschen, A., Hollinshead, M., & Smith, G. L. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-4-877 · Cited by 173
Smallpox vaccination: Risk considerations for patients with atopic dermatitis
Engler, R. J. M., Kenner, J., & Leung, D. Y. M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.128052 · Cited by 141
Self-citationContrasting disease patterns in psoriasis and atopic dermatitis
Christophers, E., & Henseler, T. (1987) · Archives of Dermatological Research · doi:10.1007/bf00585919 · Cited by 132
Tscharke, D. C., Reading, P. C., & Smith, G. L. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-8-1977 · Cited by 128
Purification and characterization of defensins from cystic fibrosis sputum
Soong, L. B., Ganz, T., Ellison, A. R., et al. (1997) · Inflammation Research · doi:10.1007/s000110050114 · Cited by 117
Innate Immunity to Viruses: Control of Vaccinia Virus Infection by γδ T Cells
Selin, L. K., Santolucito, P. A., Pinto, A. K., Szomolanyi‐Tsuda, E., & Welsh, R. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6784 · Cited by 117
Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity
Lehrer, R. I., Szklarek, D., Ganz, T., & Selsted, M. E. (1985) · Infection and Immunity · doi:10.1128/iai.49.1.207-211.1985 · Cited by 102
The Immune Response to Viruses
McFarland, H. F., & Jacobson, S. (1989) · Springer eBooks · doi:10.1007/978-1-4613-1675-6_17 · Cited by 83
Conner, K., Nern, K., Rudisill, J. A., O'Grady, T., & Gallo, R. L. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.122190 · Cited by 57
Self-citationAmegadzie, B. Y., Ahn, B. Y., & Moss, B. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92757-2 · Cited by 48
Cited by
Antimicrobial host defence peptides: functions and clinical potential
Mookherjee, N., Anderson, M. A., Haagsman, H. P., & Davidson, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0058-8 · Cited by 1,502
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense
Lai, Y., & Gallo, R. L. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.12.003 · Cited by 1,276
Self-citationAtopic dermatitis: a disease of altered skin barrier and immune dysregulation
Boguniewicz, M., & Leung, D. Y. M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01027.x · Cited by 1,073
Self-citationAntimicrobial peptides: mechanism of action, activity and clinical potential
Zhang, Q.-Y., Yan, Z.-B., Meng, Y.-M., Hong, X.-Y., Shao, G., Ma, J.-J., Cheng, X.-R., Liu, J., Kang, J., & Fu, C.-Y. (2021) · Military Medical Research · doi:10.1186/s40779-021-00343-2 · Cited by 1,065
LL-37, the only human member of the cathelicidin family of antimicrobial peptides
Dürr, U. H. N., Sudheendra, U. S., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.030 · Cited by 1,049
Metadata
- Authors
- Howell, M. D., Jones, J. F., Kisich, K. O., Streib, J. E., Gallo, R. L., & Leung, D. Y. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-02-01
- Volume
- 172
- Issue
- 3
- Pages
- 1763-1767
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2125861612
- Cited by
- 291
- References
- 20
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.